Tokyo Tape
Sign in
← D.Western Therapeutics Institute

Annual report

4576.TEDINET S100VFSO
Period2024-01-01 → 2024-12-31
Filed2025-03-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 133
MetricValuePeriodScopeSource row
Revenue¥472m2024-01-01 → 2024-12-31Cons.Net sales
Revenue¥428m2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥448m2022-01-01 → 2022-12-31dCons.Net sales (5-year summary)
Revenue¥414m2021-01-01 → 2021-12-31dCons.Net sales (5-year summary)
Revenue¥356m2020-01-01 → 2020-12-31dCons.Net sales (5-year summary)
Operating income−¥1.2bn2024-01-01 → 2024-12-31Cons.Operating income
Operating income−¥799m2023-01-01 → 2023-12-31Cons.Operating income
Ordinary income−¥1.2bn2024-01-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥796m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income−¥296m2022-01-01 → 2022-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income−¥160m2021-01-01 → 2021-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income−¥290m2020-01-01 → 2020-12-31dCons.Ordinary income loss (5-year summary)
Profit before tax−¥1.3bn2024-01-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥827m2023-01-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)−¥1.3bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥812m2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥430m2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥149m2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥276m2020-01-01 → 2020-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥1.3bn2024-01-01 → 2024-12-31Cons.Profit loss
Net income−¥828m2023-01-01 → 2023-12-31Cons.Profit loss
Total assets¥1.7bnat 2024-12-31Cons.Assets
Total assets¥2.4bnat 2023-12-31Cons.Assets
Total assets¥3.0bnat 2022-12-31dCons.Total assets (5-year summary)
Total assets¥2.5bnat 2021-12-31dCons.Total assets (5-year summary)
Total assets¥2.7bnat 2020-12-31dCons.Total assets (5-year summary)
Total liabilities¥936mat 2024-12-31Cons.Liabilities
Total liabilities¥1.1bnat 2023-12-31Cons.Liabilities
Net assets / equity¥734mat 2024-12-31Cons.Net assets
Net assets / equity¥1.3bnat 2023-12-31Cons.Net assets
Net assets / equity¥1.9bnat 2022-12-31dCons.Net assets
Net assets / equity¥2.0bnat 2021-12-31dCons.Net assets (5-year summary)
Net assets / equity¥2.2bnat 2020-12-31dCons.Net assets (5-year summary)
Cash and deposits¥1.1bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-12-31Cons.Cash and deposits
Cash & equivalents¥1.1bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2022-12-31dCons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2021-12-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥2.3bnat 2020-12-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow−¥1.3bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥587m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥355m2022-01-01 → 2022-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥176m2021-01-01 → 2021-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥216m2020-01-01 → 2020-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥10m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥15m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥140m2022-01-01 → 2022-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥111m2021-01-01 → 2021-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13m2020-01-01 → 2020-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥568m2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥134m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥867m2022-01-01 → 2022-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥104m2021-01-01 → 2021-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.0bn2020-01-01 → 2020-12-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-36.742024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.562023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-14.52022-01-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.082021-01-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-10.162020-01-01 → 2020-12-31dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥17.59at 2024-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥39.81at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥60.14at 2022-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥68.27at 2021-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥73.88at 2020-12-31dCons.Net assets per share (5-year summary)
Equity ratio43.9%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio53.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.8%at 2022-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio81.4%at 2021-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio78.9%at 2020-12-31dCons.Equity to asset ratio (5-year summary)
Employees21at 2024-12-31Cons.Number of employees
Employees21at 2023-12-31Cons.Number of employees
Employees20at 2022-12-31dCons.Number of employees
Employees19at 2021-12-31dCons.Number of employees
Employees15at 2020-12-31dCons.Number of employees
Revenue¥470m2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥428m2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥412m2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥412m2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥335m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income−¥1.2bn2024-01-01 → 2024-12-31StandaloneOperating income
Operating income−¥735m2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income−¥1.2bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥729m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥241m2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥39m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥201m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.3bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax−¥852m2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income−¥1.3bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥853m2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥387m2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income−¥241m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥202m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.6bnat 2024-12-31StandaloneAssets
Total assets¥2.4bnat 2023-12-31StandaloneAssets
Total assets¥3.0bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥2.4bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥929mat 2024-12-31StandaloneLiabilities
Total liabilities¥1.1bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥686mat 2024-12-31StandaloneNet assets
Net assets / equity¥1.3bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.9bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥2.0bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥2.2bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥1.8bnat 2023-12-31StandaloneCash and deposits
EPS (basic)¥-38.152024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-26.852023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.052022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-8.212021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-7.432020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥16.45at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥39.88at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥61.53at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥68.27at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥75.64at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio42.4%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio54.0%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio63.9%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.6%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio79.6%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued41,625,512at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued32,128,012at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued30,871,138at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued29,358,600at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued29,251,100at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees19at 2024-12-31StandaloneNumber of employees
Employees19at 2023-12-31StandaloneNumber of employees
Employees17at 2022-12-31dStandaloneNumber of employees
Employees16at 2021-12-31dStandaloneNumber of employees
Employees13at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 1,163
ItemContextValueUnit
Net assetsPrior1YearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember699000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1281896000JPY
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember743319000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember-1339857000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember1000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember1000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember1089000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember1090000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember1000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember1000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember1089000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember-595447000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-34000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-34000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember1788000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember686449000JPY
Directors compensations sgaPrior1YearDuration_NonConsolidatedMember83569000JPY
Directors compensations sgaCurrentYearDuration_NonConsolidatedMember88307000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember2493000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember2295000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)東海財務局長
Filing date cover pageFilingDateInstant2025-03-25
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第27期（自　2024年１月１日　至　2024年12月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社デ・ウエスタン・セラピテクス研究所
Company name in english cover pageFilingDateInstantD.Western Therapeutics Institute, Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　日高　有一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)名古屋市中区錦一丁目18番11号
Telephone number address of registered headquarter cover pageFilingDateInstant052－218－8785
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　　松原　さや子
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)名古屋市中区錦一丁目18番11号
Telephone number nearest place of contact cover pageFilingDateInstant052－218－8785
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　　松原　さや子
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE22024
Fund codeFilingDateInstant－
Security codeFilingDateInstant45760
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社デ・ウエスタン・セラピテクス研究所
Filer name in englishFilingDateInstantD.Western Therapeutics Institute, Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2024-01-01
Current period end dateFilingDateInstant2024-12-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass